Featured


  • ODT

    ODT's Most-Read Stories This Week—Aug. 13

    A listing of the most popular items from the past seven days.
    Michael Barbella, Managing Editor 08.13.22

  • The ODT 2022 Top 10 Orthopedic Device Companies

    The ODT 2022 Top 10 Orthopedic Device Companies

    Every member of the Top 10 posted revenue increases in their latest fiscal years—some even returned to pre-pandemic levels of growth.
    08.12.22

  • 3-D Printing/Additive Mfg.
    Additive Manufacturing at the Point of Care

    Additive Manufacturing at the Point of Care

    The flexibility additive manufacturing offers enables it to be used as a product generation solution at the point-of-care.
    Mark Crawford, Contributing Editor 08.12.22


  • Biologics
    Six Orthopedic Firms En Route to Significant Market Disruption

    Six Orthopedic Firms En Route to Significant Market Disruption

    The ODT Editors have spotlighted six companies outside the Top 10 they feel are making an impact on the device sector.
    08.12.22

  • Large Joint
    The Genetic Risk for Joint Replacement Failure

    The Genetic Risk for Joint Replacement Failure

    This could begin a new era where genetic testing prior to receiving medical implants becomes routine.
    Sam Brusco, Associate Editor 08.12.22

  • The Fundamentals of Go-To-Market Strategy in Orthopedic Medical Devices

    The Fundamentals of Go-To-Market Strategy in Orthopedic Medical Devices

    Getting the fundamentals right in go-to-market strategy, especially for disruptive products, is critical to success.
    Maria Shepherd, President and Founder, Medi-Vantage 08.12.22


  • Minding the Gap: How Harmonizing Quality Systems Pays Off

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    FDA issued a proposed rule to harmonize 21 CFR 820 with ISO 13485, which could save medical device companies $439 to $533 million over a decade.
    Dawn A. Lissy, Founder & President, Empirical 08.12.22

  • Contract Manufacturing
    Four Key Considerations for OEMs Transferring a Product Program

    Four Key Considerations for OEMs Transferring a Product Program

    Transferring programs can offer a variety of advantages—including with regard to streamlining resources.
    Todd Owens, Vice President of Engineering, Donatelle 08.12.22

  • Trouble Finding Talent? Three People-Centric Measures to Edge Out Competitors

    Trouble Finding Talent? Three People-Centric Measures to Edge Out Competitors

    A growing skills gap is a significant concern for CEOs everywhere. In fact, for the Fortune 500, talent is their biggest worry.
    Tania de Decker, Managing Director—Global Strategic Accounts, Randstad Enterprise Group 08.12.22


  • Supply Chain
    The Interdependence of Supply Chain Stability and World Peace

    The Interdependence of Supply Chain Stability and World Peace

    Supply chains and world peace are codependent—one cannot exist without the other.
    Chris Oleksy, Founder and CEO, Oleksy Enterprises and Co-Founder/CEO, Next Life Medical; CEO, Emergent Respiratory; Founder, SCHAIN101.COM 08.12.22

  • The Case for Using Historical Control in Clinical Trial Design

    The Case for Using Historical Control in Clinical Trial Design

    Historical control refers to the use of data from past studies to estimate potential response to a placebo or standard care treatment among trial patients.
    Michael Coladonato and Lucas Tatem, MCRA 08.12.22

  • Supply Chain
    Orthopedic Device OEMs Recover Rapidly to Face Supply Chain Challenges

    Orthopedic Device OEMs Recover Rapidly to Face Supply Chain Challenges

    ODT's Top Company reports reveal a recovery for orthopedic device makers, but now they face a supply chain crisis.
    Sean Fenske, Editor-in-Chief 08.12.22

  • Surgalign, RTI Settle Lawsuit Over OEM Biz Sale

    Surgalign, RTI Settle Lawsuit Over OEM Biz Sale

    The parties amended various agreements, including distribution agreements for spinal implants and biologics.
    Sam Brusco, Associate Editor 08.10.22

  • 3-D Printing/Additive Mfg. | Materials
    Stratasys to Buy Covestro

    Stratasys to Buy Covestro's 3D Printing Materials Biz for €43M

    Stratasys will gain a portfolio of about 60 additive manufacturing materials.
    Sam Brusco, Associate Editor 08.09.22

  • 3-D Printing/Additive Mfg. | Extremities
    Custom 3D-Printed Titanium Lower Jaw Used in First Successful Surgery

    Custom 3D-Printed Titanium Lower Jaw Used in First Successful Surgery

    Has the shape and weight of the original mandible and is stronger than currently used plates.
    Sam Brusco, Associate Editor 08.09.22

Loading, Please Wait..